Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 323
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07258745 | Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants | ||
| NCT03849287 | Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults | ||
| NCT04627207 | A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers | ||
| NCT02002611 | Drug-drug Interaction Study(Lobeglitazone, Warfarin) | ||
| NCT03627182 | Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes | ||
| NCT03749356 | Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients | ||
| NCT02356679 | Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients | ||
| NCT05041790 | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment | ||
| NCT02645890 | Study to Compare the Safety and Pharmacokinetics of CKD-397 | ||
| NCT05931224 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy | ||
| NCT04223895 | A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers | ||
| NCT05540912 | Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects | ||
| NCT03067415 | Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily | ||
| NCT04156685 | Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1 | ||
| NCT01356017 | CKD-828 Drug Interaction Study (Telmisartan) | ||
| NCT06204107 | A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379 | ||
| NCT01983735 | Efficacy and Safety of TELMINUVO to Stage 2 Hypertension | ||
| NCT03770052 | Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie | ||
| NCT02206165 | A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension | ||
| NCT06916793 | A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia | ||
| NCT01842269 | Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients | ||
| NCT07215637 | Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors | ||
| NCT01956201 | Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin | ||
| NCT07439094 | A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer | ||
| NCT06942156 | Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea | ||
| NCT04204603 | A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate | ||
| NCT01341392 | Drug-drug Interaction Study(CKD-501, Amlodipine) | ||
| NCT02588937 | Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients | ||
| NCT02044250 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM) | ||
| NCT03739125 | Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes | ||
| NCT03858725 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers | ||
| NCT03017950 | Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 | ||
| NCT03950843 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation | ||
| NCT06399068 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions | ||
| NCT03601910 | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg | ||
| NCT04255589 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 | ||
| NCT02623868 | Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. | ||
| NCT02824874 | CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) | ||
| NCT01630018 | Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial | ||
| NCT07532148 | Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ||
| NCT02005744 | A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function | ||
| NCT02156544 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT03802162 | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 | ||
| NCT04706286 | Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393 | ||
| NCT03233932 | CKD-841 Pharmacokinetic/Pharmacodynamic Study | ||
| NCT04810676 | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383. | ||
| NCT04628143 | A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | ||
| NCT06281132 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults | ||
| NCT03794492 | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome | ||
| NCT05192356 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) |
